The whole wager, before the fine print
- A free health quiz became a route to special-rate life insurance.
- The brokerage earned commissions, not premiums.
- Medicare plan matching became the second act in 2019.
- Precision Medicare read health records and compared thousands of plans.
- A costly sales engine ran ahead of its cash.
- Chapter 7 arrived on August 30, 2023.
The neatest version of Health IQ fit inside a single question: why should a marathon runner who knows the difference between a triglyceride and a carbohydrate be priced like everybody else? In 2010, entrepreneur Munjal Shah had chest pains after a 10K. He was 37; his father had suffered a first heart attack at 45. Shah lost roughly 40 pounds, ran three marathons and became the sort of person who reads labels for sport. Then he built a company around the suspicion that this effort ought to be worth money.
Health IQ began in 2013 as a quiz. Not a lead form dressed up with three cheerful questions, but a broad test of knowledge across diet, exercise and medicine. By 2017, more than a million people had taken it. Shah described the result with founderly grandeur: he believed the company had stumbled into a new mortality table. The quiz knew something conventional underwriting missed - not merely whether a person was healthy on examination day, but whether that person had made health a practice.
The eight-minute-mile discount
The product became tangible when Health IQ turned knowledge into an insurance advantage. Pass the quiz and, according to the company at the time, a customer could qualify for a 4 percent life-insurance discount. Meet a verified fitness threshold, such as running an eight-minute mile, and another 4 percent could follow. Health IQ also shopped the applicant across carriers. It was a broker, not the company assuming the risk, and it collected a commission when a policy sold.
This was clever differentiation in a market full of beige comparison forms. Policygenius could simplify shopping. A carrier could advertise a rate. Health IQ told a flattering story about the buyer: your discipline is real, we see it, and we will argue that it changes your risk. Customers included runners, cyclists, weightlifters, vegans and people who had learned to manage chronic illness. The brokerage did not sell only a policy; it sold recognition.
“Our product IS data science. It’s digital data science wrapped in an insurance contract.”Munjal Shah, describing the company’s operating thesis
The culture followed the product. Early recruits were asked for work samples and a “brag sheet,” and each person needed a health story of their own. Common areas stocked healthy snacks. Internal software could carry the name of the engineer who made it - Tom’s CRM became TRM. The language was celebration, ownership and optimism. It was memorable, sometimes charming and occasionally clumsy. A recruiting page drew criticism for wording that sounded like “fit supremacy.” Shah acknowledged that the company had written it badly.
Then the customer got older
By 2019, Health IQ changed the question. Federal rules do not let healthy people pay a lower Medicare premium simply because they ace a quiz. But Medicare Advantage gives seniors a thicket of private plans whose doctor networks, drug formularies, copays and supplemental benefits vary by county. Health IQ moved from rewarding present behavior to predicting future need.
Precision Medicare, reduced to three boxes
Precision Medicare imported detailed records with a senior’s permission. It interpreted procedure and diagnosis codes, considered prescriptions and tried to forecast what might happen next. If pain-management visits and opioid dosage suggested a knee replacement was coming, the engine could favor plans with better economics around that procedure. It searched more than 3,000 plans; in a late-2022 interview, Shah said the national universe had moved closer to 4,000.
That was a more consequential recommendation than “people like you also bought this.” A Medicare plan determines whether a specialist is in network, how a medicine is tiered and how much a patient pays for care. The idea works best where choice is broad, records are rich and plan data is current. It works poorly where only a few plans exist, where records are thin, or where formularies and networks change faster than the recommendation system can follow.
The cost hid in the clock
Health IQ’s Medicare customers did not pay for the matching service. Carriers paid commissions when the brokerage enrolled someone. Forbes reported that the company estimated one Medicare Advantage enrollment could be worth more than $1,300 over three years. The phrase “over three years” carried the entire risk. Agents and lead vendors needed cash now. The customer value arrived later, and not in full if the senior switched plans.
The company had capital. Its November 2017 Series C brought $34.6 million, led by Andreessen Horowitz. A $55 million Series D in May 2019 took disclosed equity funding to roughly $139.5 million and valued the company at about $450 million. Equity, debt and convertible notes later pushed the total capital raised above $200 million. In March 2021, Health IQ explored a blank-check merger that could have valued it above $1.5 billion. The deal never happened.
The first visible break was operational. On December 8, 2022, just after Medicare’s annual enrollment period, Health IQ began laying off hundreds of employees and contractors. Former workers filed claims alleging they had not received legally required notice. Vendors were already pursuing unpaid invoices. More than a dozen lawsuits alleged over $17 million was owed, and court filings would later list seventeen breach-of-contract cases as pending. Health IQ disputed some claims, but not the broader fact of a cash crisis.
What changed management’s mind was not a rejection of personalized insurance. It was the disappearance of financing. Shah later said he spent that Christmas approaching dozens of investors. The rescue did not come. He stepped back in early 2023; co-founder Gaurav Suri became CEO. The Precision Medicare intellectual property sold for $4.5 million to an undisclosed buyer, with Health IQ stating that no patient data transferred.
The company was built to see risks that ordinary insurance missed. The one it could not price was its own dependence on the next dollar.
A balance sheet replaces the pitch deck
On August 30, 2023, Hi.Q, Inc. filed Chapter 7 in Delaware. The filing put hard edges around the collapse: $1.3 million in assets, $256.7 million in liabilities, including $67.5 million of secured debt and $189.2 million of unsecured claims. The company that had considered a billion-dollar public-market future would liquidate. The filing date matters: it was 2023, not 2024, a small correction with a large year attached.
Health IQ’s distinction survives its company. Life insurance had long measured cholesterol, blood pressure and family history. Health IQ asked whether knowledge and sustained habits could add signal. Medicare brokers had long asked for doctors and drugs. Precision Medicare asked whether the whole record could anticipate next year. In both cases, it made the consumer feel less like a row in a table.
Health IQ sat between carriers and consumers: part brokerage, part recommendation engine, part health-data company. It competed for attention with digital brokers such as Policygenius and SelectQuote, and for Medicare enrollments with eHealth, GoHealth and Assurance IQ. Its software was differentiated; its commission economics were familiar.
What another builder can steal
- Begin with a sentence a customer can repeat. “Your healthy work should earn a better rate” did more work than a page of insurtech vocabulary.
- Use data to make the buyer feel seen. The quiz was not merely qualification. It recognized an identity that standard underwriting ignored.
- Apply prediction where choices have consequences. Records matter in Medicare because networks, drugs and expected procedures can make similar-looking plans behave very differently.
- Model the cash clock, not only lifetime value. A three-year commission cannot pay a December vendor invoice unless financing reliably bridges the gap.
- Keep the method alive without keeping the mythology. Health IQ’s personalization thesis remains useful. Its growth trajectory is a warning, not a requirement.
The approach is least likely to work when the recommendation engine has sparse records, stale plan data or too little choice to improve upon; when regulation limits how health signals may affect pricing; or when customer-acquisition expense arrives far ahead of durable revenue. It also fails morally when “health conscious” becomes a flattering synonym for fortunate. Genes, disability, income, time and access all influence the behaviors a quiz can celebrate.
Health IQ had a rare talent for turning an actuarial idea into a human one. It asked customers to show their work, and promised that somebody in insurance would finally notice. The product deserved the attention. The ending asks for a different kind of notice: a beautiful recommendation can still sit on top of a business whose timing is wrong.